Why the study?
Does glycerol-blanked triglyceride measurement improve accurate triglyceride assessment in patients with known or suspected pseudohypertriglyceridemia?
Does glycerol-blanked triglyceride measurement improve accurate triglyceride assessment in patients with known or suspected pseudohypertriglyceridemia?
Identifying pseudohypertriglyceridemia and using glycerol-blanked triglyceride measurements prevents overestimation of cardiovascular risk and unnecessary lipid-lowering therapy.
Answers are grounded in this paper and cite their sources.
May support glycerol blanking in suspected pseudohypertriglyceridemia; leaves open impact on outcomes and practice.
Isolated asymptomatic glycerol kinase deficiency (GKD) or ‘pseudohypertriglyceridemia’, is an X-linked recessive disorder resulting in hyperglyceroluria and hyperglycerolemia. Patients typically present with hypertriglyceridemia, which is unresponsive to therapy. The falsely elevated triglycerides are a result of clinical laboratories utilizing glycerol levels to report triglyceride concentrations. Glycerol blanking will account for the excess glycerol and provide accurate triglyceride measures. Pseudohypertriglyceridemia is linked to glucose impairment and other forms of GKD involving childhood metabolic crises and developmental limitations. Identifying patients with pseudohypertriglyceridemia prevents overestimation of cardiovascular risk and exposure to unnecessary lipid-altering agents; and heightens the awareness of the potential for symptomatic GKD in male offspring. We urge clinical labs to provide a glycerol-blanked triglyceride measurement for known or suspected pseudohypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Backes et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: